What are the diagnostic criteria for systemic sclerosis?

Diagnostic Criteria for Systemic Sclerosis

The 2013 ACR/EULAR classification criteria for systemic sclerosis should be used, as they demonstrate superior sensitivity (91%) and specificity (92%) compared to the older 1980 ACR criteria, particularly for early and limited disease. 1

Sufficient Criterion for Classification

Skin thickening of the fingers extending proximal to the metacarpophalangeal (MCP) joints is sufficient alone to classify a patient as having systemic sclerosis. 1 This single finding carries enough weight to establish the diagnosis without requiring additional criteria.

Additive Scoring System (When Proximal Skin Thickening Absent)

If the patient does not have skin thickening proximal to the MCP joints, use the following point-based system. A total score of ≥9 points classifies the patient as having systemic sclerosis: 1

Skin Manifestations

• Puffy fingers: 2 points 1
• Sclerodactyly (skin thickening of fingers): 4 points 1

Fingertip Lesions

• Digital tip ulcers: 2 points 1
• Fingertip pitting scars: 3 points 1

Vascular Manifestations

• Telangiectasias: 2 points 1
• Abnormal nailfold capillaries: 2 points 1
• Raynaud's phenomenon: 3 points 1

Pulmonary Involvement

• Pulmonary arterial hypertension: 2 points 1
• Interstitial lung disease: 2 points 1

Serologic Markers

• SSc-related autoantibodies (anti-centromere, anti-topoisomerase I [anti-Scl-70], or anti-RNA polymerase III): 3 points 1

Performance Characteristics and Clinical Context

The 2013 ACR/EULAR criteria significantly outperform the 1980 ACR criteria, with sensitivity increasing from 75% to 91% and specificity from 72% to 92% in validation studies. 1 This improvement is particularly pronounced in early systemic sclerosis, where only 28% of patients met the old criteria but substantially more are now captured. 2

Among patients with early disease who have the triad of Raynaud's phenomenon, abnormal capillaroscopy, and positive SSc-related antibodies, 53% meet the 2013 criteria. 2 The optimal cut-off score in validation studies was ≥8 points (sensitivity 82%, specificity 97.9%), though the official threshold remains ≥9 points. 2

Individual Variable Performance

The most specific individual findings are: 2

• Proximal skin thickening and sclerodactyly: 100% specificity
• Telangiectasias and SSc-related antibodies: 98.6% specificity

Raynaud's phenomenon has the highest sensitivity (99.4%) but very low specificity (4.2%), making it an excellent screening feature but insufficient alone for classification. 2

Critical Clinical Pitfalls

All cases that met the 1980 ACR criteria also meet the 2013 ACR/EULAR criteria, but the reverse is not true—the new criteria capture additional patients with milder, earlier, or limited disease who would have been missed previously. 1 This represents a fundamental shift toward earlier disease recognition and intervention.

The new criteria emphasize vasculopathic manifestations and include puffy fingers as an early sign, allowing classification before irreversible fibrosis develops. 3 This earlier classification creates opportunities to intervene and potentially prevent disease progression. 3

When applying these criteria, remember they are classification criteria designed for research cohorts and clinical trial enrollment, not diagnostic criteria for individual patient care. 1 However, they provide an evidence-based framework for recognizing systemic sclerosis in clinical practice, particularly in its early stages when therapeutic intervention may be most beneficial. 4